Impact of diagnostic immunohistochemistry on the recognition and management of two cases of thyroid cancer with protracted courses.
This report presents two cancer cases with protracted courses in which diagnostic immunohistochemistry for thyroglobulin and/or calcitonin was performed several years after the original light microscopic interpretation. In both cases, diagnostic immunohistochemistry suggested significant changes in tumor classification. In light of current controversies and interpretive problems in this area, confirmatory tests for serum calcitonin and serum thyroglobulin and scans for iodine 131 uptake were performed. These confirmed the immunohistochemical evidence, and led to major changes in patient management. Several similar cases were found in the literature. In cancer cases with a protracted course, but with atypical or discordant clinical and/or pathologic features, diagnostic immunohistochemistry for thyroid markers may merit consideration because of the potential for meaningful changes in clinical management.
Cramer
S F
SF
Rosenthal
S N
SN
Swinburne
A J
AJ
Lewis
C L
CL
D000230:Adenocarcinoma / Q000032:analysis* / Q000473:pathology / Q000628:therapy; D002116:Calcitonin / Q000032:analysis; D002277:Carcinoma / Q000032:analysis* / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D013954:Thyroglobulin / Q000032:analysis; D013964:Thyroid Neoplasms / Q000032:analysis* / Q000473:pathology / Q000628:therapy
D002116:Calcitonin; D013954:Thyroglobulin